Jacobs Levy Equity Management’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.36M | Sell |
|
|||||
|
2025
Q1 | $1.74M | Buy |
|
|||||
|
2024
Q4 | $2.62M | Sell |
|
|||||
|
2024
Q3 | $5.56M | Sell |
|
|||||
|
2024
Q2 | $5.56M | Sell |
|
|||||
|
2024
Q1 | $14.7M | Sell |
|
|||||
|
2023
Q4 | $9.79M | Buy |
|
|||||
|
2023
Q3 | $5.06M | Buy |
|
|||||
|
2023
Q2 | $11.1M | Buy |
|
|||||
|
2023
Q1 | $7.66M | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $65K | Sell |
|
|||||
|
2017
Q2 | $162K | Sell |
|
|||||
|
2017
Q1 | $276K | Sell |
|
|||||
|
2016
Q4 | $236K | Sell |
|
|||||
|
2016
Q3 | $388K | Sell |
|
|||||
|
2016
Q2 | $304K | Sell |
|
|||||
|
2016
Q1 | $368K | Buy |
|
|||||
|
2015
Q4 | $126K | Buy |
|